-+ 0.00%
-+ 0.00%
-+ 0.00%

TONIX PHARMACEUTICALS ANNOUNCES ON-LINE PUBLICATION OF PHASE 3 RESILIENT TRIAL RESULTS OF TNX-102 SL FOR FIBROMYALGIA IN THE PEER REVIEWED JOURNAL, PAIN MEDICINE

Reuters·07/09/2025 20:01:00

Please log in to view news